Brugada Syndrome

被引:79
作者
Benito, Begona [1 ]
Brugada, Josep [2 ]
Brugada, Ramon [3 ]
Brugada, Pedro [4 ]
机构
[1] Montreal Heart Inst, Res Ctr, Electrophysiol Res Program, Montreal, PQ H1T 1C8, Canada
[2] Hosp Clin Barcelona, Serv Cardiol, Inst Clin Torax, Barcelona, Spain
[3] Univ Girona, Ctr Genet Cardiovasc, Girona, Spain
[4] UZ Brussel, Cardiovasc Inst, Heart Rhythm Management Ctr, Bruselas, Belgium
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2009年 / 62卷 / 11期
关键词
Sudden death; Ions; Channelopathies; Ventricular fibrillation; ST-SEGMENT-ELEVATION; BUNDLE-BRANCH BLOCK; SUDDEN CARDIAC DEATH; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; PRECORDIAL LEADS V-1; T-WAVE ALTERNANS; TERM-FOLLOW-UP; VENTRICULAR-FIBRILLATION; ELECTROCARDIOGRAPHIC PATTERN; ATRIAL-FIBRILLATION;
D O I
10.1016/S0300-8932(09)73082-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
First described in 1992, Brugada syndrome is characterized by a specific electrocardiographic pattern in the right precordial leads and susceptibility to ventricular arrhythmias and sudden death. Brugada syndrome is included among the channelopathies, primary electrical disorders that, characteristically, are not associated with concomitant structural cardiac abnormalities. In recent years, substantial preclinical and clinical research has led to the identification of multiple causative mutations and to understanding of the mechanisms underlying the development of the characteristic phenotype and of the factors that determine clinical prognosis in patients. Nevertheless, there remain numerous unresolved questions which provide an impetus for ongoing active research into the condition. This article provides a summary of what is currently known about Brugada syndrome and an overview of the principal preclinical and clinical studies that have made the most significant contributions to our understanding of the condition.
引用
收藏
页码:1297 / 1315
页数:19
相关论文
共 81 条
[71]   Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome [J].
Tada, Takeshi ;
Kusano, Kengo Fukushima ;
Nagase, Satoshi ;
Banba, Kimikazu ;
Miura, Daiji ;
Nishii, Nobuhiro ;
Watanabe, Atsuyuki ;
Nakamura, Kazufumi ;
Morita, Hiroshi ;
Ohe, Tohru .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2008, 19 (01) :56-61
[72]   Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome [J].
Takigawa, Masateru ;
Noda, Takashi ;
Shimizu, Wataru ;
Miyamoto, Koji ;
Okamura, Hideo ;
Satomi, Kazuhiro ;
Suyama, Kazuhiro ;
Aihara, Naohiko ;
Kamakura, Shiro ;
Kurita, Takashi .
HEART RHYTHM, 2008, 5 (11) :1523-1527
[73]  
van den Berg MP, 2009, J AM COLL CARDIOL, V53, P1569, DOI 10.1016/j.jacc.2008.12.057
[74]   Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome [J].
Vatta, M ;
Dumaine, R ;
Varghese, G ;
Richard, TA ;
Shimizu, W ;
Aihara, N ;
Nademanee, K ;
Brugada, R ;
Brugada, J ;
Veerakul, G ;
Li, H ;
Bowles, NE ;
Brugada, P ;
Antzelevitch, C ;
Towbin, JA .
HUMAN MOLECULAR GENETICS, 2002, 11 (03) :337-345
[75]   Novel mutations in domain I of SCN5A cause Brugada syndrome [J].
Vatta, M ;
Dumaine, R ;
Antzelevitch, C ;
Brugada, R ;
Li, H ;
Bowles, NE ;
Nademanee, K ;
Brugada, J ;
Brugada, P ;
Towbin, JA .
MOLECULAR GENETICS AND METABOLISM, 2002, 75 (04) :317-324
[76]   A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification [J].
Veltmann, Christian ;
Schimpf, Rainer ;
Echternach, Constanze ;
Eckardt, Lars ;
Kuschyk, Juergen ;
Streitner, Florian ;
Spehl, Susanne ;
Borggrefe, Martin ;
Wolpert, Christian .
EUROPEAN HEART JOURNAL, 2006, 27 (21) :2544-2552
[77]   Clinical and molecular heterogeneity in the Brugada syndrome - A novel gene locus on chromosome 3 [J].
Weiss, R ;
Barmada, MM ;
Nguyen, T ;
Seibel, JS ;
Cavlovich, D ;
Kornblit, CA ;
Angelilli, A ;
Villanueva, F ;
McNamara, DM ;
London, B .
CIRCULATION, 2002, 105 (06) :707-713
[78]   Proposed diagnostic criteria for the Brugada syndrome [J].
Wilde, AAM ;
Antzelevitch, C ;
Borggrefe, M ;
Brugada, J ;
Brugada, R ;
Brugada, P ;
Corrado, D ;
Hauer, RNW ;
Kass, RS ;
Nademanee, K ;
Priori, SG ;
Towbin, JA .
EUROPEAN HEART JOURNAL, 2002, 23 (21) :1648-1654
[79]   Spontaneous electrocardiographic fluctuations in Brugada syndrome: does it matter? [J].
Wilde, Arthur A. M. .
EUROPEAN HEART JOURNAL, 2006, 27 (21) :2493-2494
[80]   Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome [J].
Wolpert, C ;
Echternach, C ;
Veltmann, C ;
Antzelevitch, C ;
Thomas, GP ;
Spehl, S ;
Streitner, F ;
Kuschyk, J ;
Schimpf, R ;
Haase, KK ;
Borggrefe, M .
HEART RHYTHM, 2005, 2 (03) :254-260